UNSPSC 85818723: Transfusion of nonautologous frozen plasma into central artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous frozen plasma into central artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30263K1

UNSPSC 85818723 Transfusion of nonautologous frozen plasma into central artery, percutaneous approach is a Commodity code that shows little relevant recent activity aligned with its nominal scope. The recent opportunities posted under this code—independent medical evaluation services for pension disability determinations, surgical carve-out benefit program administration, occupational medical surveillance, specialty and emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—do not involve transfusion of frozen plasma or percutaneous arterial procedures. The mismatch suggests either miscoding at the source or that state and local procurement offices are tagging broadly clinical services under a procedure-specific code rather than classifying them to their actual commodity or service family. No solicitations in the recent-opportunities block reflect direct procurement of transfusion products, transfusion services, or related clinical supplies and labor aligned with the code's stated medical procedure.

The issuing bodies across the recent postings span diverse public entities—state health systems (Santa Clara County Health System, Washington State Department of Transportation), county governments (Harris County Juvenile Probation Department, Collier County Board of County Commissioners), municipalities (City of Phoenix Retirement Office, City of Long Beach)—and represent workforce medical management, benefits administration, and occupational health rather than acute transfusion or vascular intervention. Geographic presence appears across California, Florida, Texas, Washington, and Arizona, but the underlying services procured do not align with the code's stated commodity. Business development professionals should not pursue this code based on transfusion-service capability; the tagging appears to be administrative misclassification rather than a signal of genuine market activity under the code's intended scope.